Covered recipient · General Payments record
ROBERT SIDBURY
Allopathic & Osteopathic Physicians Dermatology Pediatric Dermatology
General Payments · PY2019–2024
$48,357.19
- Reported across 31 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $8,672.50 | 4 |
| Honoraria | $300.00 | 1 |
| Food and Beverage | $222.07 | 4 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| LEO Pharma Inc. | $3,252.31 | 2 |
| Dermavant Sciences, Inc. | $3,228.62 | 2 |
| Lilly USA, LLC | $2,000.00 | 1 |
| ABBVIE INC. | $350.00 | 1 |
| CHIESI USA, INC. | $300.00 | 1 |
| PFIZER INC. | $43.00 | 1 |
| Arcutis Biotherapeutics, Inc. | $20.64 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $350.00 | 08/19/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106096771 | CMS |
| Arcutis Biotherapeutics, Inc. | $20.64 | 06/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121070732 | CMS |
| Chiesi USA, Inc. | $300.00 | 12/26/2024 | Honoraria | Undisputed | 01/23/2026 | 1151821026 | CMS |
| Dermavant Sciences, Inc. | $3,120.00 | 07/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1127933683 | CMS |
| Dermavant Sciences, Inc. | $108.62 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127933687 | CMS |
| LEO Pharma Inc. | $49.81 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152651305 | CMS |
| LEO Pharma Inc. | $3,202.50 | 07/15/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1152651307 | CMS |
| Lilly USA, LLC | $2,000.00 | 02/29/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1135369228 | CMS |
| PFIZER INC. | $43.00 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131201986 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.